Immunome Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Immunome Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Immunome Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 59.9M shares, a 391% increase year-over-year.
  • Immunome Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19.8M shares, a 63.6% increase from 2022.
  • Immunome Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.1M shares, a 5.1% increase from 2021.
  • Immunome Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 11.5M shares, a 240% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 59.9M +47.7M +391% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 51.5M +39.4M +323% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 19.8M +7.72M +63.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 12.2M +74.8K +0.62% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 12.2M +70.4K +0.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 12.2M +59.6K +0.49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 12.1M +588K +5.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.1M +193K +1.62% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 12.1M +670K +5.85% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 12.1M +1.48M +13.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 11.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 11.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 11.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 10.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.